Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis

被引:25
|
作者
Kühbacher, T
Gionchetti, P
Hampe, J
Helwig, U
Rosenstiel, P
Campieri, M
Buhr, HJ
Schreiber, S
机构
[1] CAU Kiel, Dept Med 1, Kiel, Germany
[2] CAU Kiel, Dept Anat, Kiel, Germany
[3] Univ Bologna, Dept Internal Med & Gastroenterol, I-40126 Bologna, Italy
[4] Free Univ Berlin, Benjamin Franklin Univ Hosp, Dept Surg, D-1000 Berlin, Germany
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2001年 / 123卷 / 03期
关键词
inflammation; ulcerative colitis; signal transduction; intestinal mucosa; pelvic ileal pouch;
D O I
10.1046/j.1365-2249.2001.01455.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Activation of signal transducer and activator of transcription 1 (STAT1) is a hallmark of IFN-gamma receptor signal transduction but is also part of the signalling pathway of other cytokines/growth factor receptors. In ulcerative colitis, high levels of activation and expression of STAT1 have been observed in comparison with both Crohn's Disease and normal controls. Pouchitis develops in some patients after Ileal-Pouch-Anal-Anastomosis (IPAA). The pathophysiology and aetiology of pouchitis is still unclear. Recent studies have shown an increased production of proinflammatory cytokines including IFN-gamma. To investigate the expression and activation of STAT1 in pouchitis and the influence of treatment, patients were followed longitudinally from pouch operation. Diagnosis of pouchitis was made by clinical, endoscopic and histological criteria. Biopsies were obtained during routine endoscopy and snap frozen in liquid nitrogen. Nuclear and cytosolic extracts were prepared and the expression and activation of specific transcription factors were assessed by Western blot, electrophoretic mobility shift assay and immunofluorescence. Patients who develop pouchitis show highly increased levels of STAT1 alpha as well as STAT1 beta expression and activation in comparison with both normal pouch and normal ileal mucosa. Improvement of pouchitis during antibiotic therapy relates to a normalization of STAT1 expression and activation. We conclude that activation of STAT1 correlates to clinical disease activity and therefore STAT1 could play an important role in the pathophysiology of pouchitis. Similarities in the pattern of activation of STAT1 in pouchitis and ulcerative colitis may suggest a common pathway in the immunopathophysiology of both diseases.
引用
收藏
页码:395 / 401
页数:7
相关论文
共 50 条
  • [1] Functional analysis of Rousettus aegyptiacus "signal transducer and activator of transcription 1" (STAT1)
    Fujii, Hikaru
    Watanabe, Shumpei
    Yamane, Daisuke
    Ueda, Naoya
    Iha, Koichiro
    Taniguchi, Satoshi
    Kato, Kentaro
    Tohya, Yukinobu
    Kyuwa, Shigeru
    Yoshikawa, Yasuhiro
    Akashi, Hiroomi
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2010, 34 (05): : 598 - 602
  • [2] An excessive activation of signal transducer and activator of transcription 1 (Stat1) inhibits proliferation of chondrocytes in achondroplasia.
    Yamanaka, Y
    Tanaka, H
    Koike, M
    Nishimura, R
    Seino, Y
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S163 - S163
  • [3] OUTCOME OF PATIENTS WITH SIGNAL-TRANSDUCER AND ACTIVATOR OF OF TRANSCRIPTION 1 (STAT1) GAIN-OF-FUNCTION VARIANTS AFTER HAEMATOPOIETIC STEM CELL TRANSPLANTATION
    Buddingh, Emilie Pauline
    Slatter, Mary A.
    Kiykim, Ayca
    Alonso Garcia, Laura
    Leahy, T. R.
    Chellapandian, Deepak
    Formankova, Renata
    Kuehl, Joern-Sven
    Baris, Safa
    Morris, Emma
    Sedlacek, Petr
    Laberko, Alexandra
    Riviere, Jacques
    Keogh, Steven
    Torgerson, Troy
    Albert, Michael
    Neven, Benedicte
    Leiding, Jennifer
    Schuetz, Catharina
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 392 - 393
  • [4] Signal Transducer and Activator of Transcription 1 (STAT1) is a Transcriptional Inhibitor of VEGF Gene Expression
    Labazi, M.
    Marcus, D. M.
    Lamoke, F.
    Varano, M.
    Caldwell, R. B.
    Bartoli, M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [5] Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1)
    Chawla-Sarkar, M
    Leaman, DW
    Jacobs, BS
    Tuthill, RJ
    Chatterjee-Kishore, M
    Stark, GR
    Borden, EC
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2002, 22 (05): : 603 - 613
  • [6] Signal transducer and activator of transcription 1 (STAT1) acts like an oncogene in malignant pleural mesothelioma
    Arzt, Lisa
    Kothmaier, Hannelore
    Halbwedl, Iris
    Quehenberger, Franz
    Popper, Helmut H.
    VIRCHOWS ARCHIV, 2014, 465 (01) : 79 - 88
  • [7] Signal transducer and activator of transcription 1 (STAT1) acts like an oncogene in malignant pleural mesothelioma
    Lisa Arzt
    Hannelore Kothmaier
    Iris Halbwedl
    Franz Quehenberger
    Helmut H. Popper
    Virchows Archiv, 2014, 465 : 79 - 88
  • [8] Antiproliferative mechanisms of a transcription factor decoy targeting signal transducer and activator of transcription (STAT) 3: The role of STAT1
    Lui, Vivian Wai Yan
    Boehm, Amanda L.
    Koppikar, Priya
    Leeman, Rebecca J.
    Johnson, Daniel
    Ogagan, Michelene
    Childs, Erin
    Freilino, Maria
    Grandis, Jennifer Rubin
    MOLECULAR PHARMACOLOGY, 2007, 71 (05) : 1435 - 1443
  • [9] The Role of Signal Transducer and Activator of Transcription protein 1 (STAT1) in a murine model of lung adenocarcinoma (ADC)
    Friedrich, Juliane
    Kross, Bettina
    Trump, Sonja
    Holzinger, Corinna
    Chiriac, Mircea
    Finotto, Susetta
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [10] Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis
    Sampaio, Elizabeth P.
    Hsu, Amy P.
    Pechacek, Joseph
    Bax, Hannelore I.
    Dias, Dalton L.
    Paulson, Michelle L.
    Chandrasekaran, Prabha
    Rosen, Lindsey B.
    Carvalho, Daniel S.
    Ding, Li
    Vinh, Donald C.
    Browne, Sarah K.
    Datta, Shrimati
    Milner, Joshua D.
    Kuhns, Douglas B.
    Priel, Debra A. Long
    Sadat, Mohammed A.
    Shiloh, Michael
    De Marco, Brendan
    Alvares, Michael
    Gillman, Jason W.
    Ramarathnam, Vivek
    de la Morena, Maite
    Bezrodnik, Liliana
    Moreira, Ileana
    Uzel, Gulbu
    Johnson, Daniel
    Spalding, Christine
    Zerbe, Christa S.
    Wiley, Henry
    Greenberg, David E.
    Hoover, Susan E.
    Rosenzweig, Sergio D.
    Galgiani, John N.
    Holland, Steven M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (06) : 1624 - +